ImPRESS · International Interdisciplinary PhD studies in Biomedical Research and Biostatistics. Supporting the career and training in omic-based research and biostatistics by inter-national and-sectoral mobility

International Interdisciplinary PhD studies in Biomedical Research and Biostatistics. Supporting the career and training in omic-based research and biostatistics by inter-national and-sectoral mobility

The aim of the ImPRESS project was to launch International Interdisciplinary PhD Studies in Biomedical Research and Biostatistics aimed at young scientists conducting research on lifestyle diseases and on biostatistics and bioinformatics methods necessary to process and interpret data obtained in research projects. The ImPRESS project has received cofunding from the Polish Ministry of Science and Higher Education, from financial resources for science in 2018-2023 granted for the implementation of an international co-financed project. The newly created ImPRESS PhD Studies provide an outstanding opportunity for in-depth education in high-throughput experimental and computational techniques used in genomics, proteomics, metabolomics, and immunology. PhD students were involved in large-scale scientific projects carried out with excellent researchers from European centers. The aim of the Early Stage Researchers projects was searching for new markers for early detection and prevention together with biomarkers of effective individualized therapy of civilization diseases (also referred to as lifestyle diseases or non-communicable disease) based on innovative large-scale (high-throughput) technologies including genomics, transcriptomics, epigenomics, proteomics, metabolomics, and cutting-edge hybrid PET/MR imaging for diagnosis and research. According to the WHO report, the number of patients suffering from civilization diseases, the main health hazards for society such as cancer (lung cancer, brain tumors), cardiovascular diseases, obesity and type 2 diabetes, and Central Nervous System (CNS) diseases (Alzheimer's disease), increases in the rate of an epidemic (it will increase 2-3 times until 2030). In many cases there is no effective treatment, which generates huge costs for state budgets. The use of biomarkers may allow for early detection, prevention and therapy individualization of these diseases. Modern research on biomarkers is conducted using state of the art advanced technologies in the field of genomics, proteomics, transcriptomics and metabolomics which was the main subject of the PhD studies. Cooperation with strong partner organisations: CEMBIO from San Pablo University; National Centre for Cardiovascular Research from Spain, Szentágothai Research Centre from University of Pécs, Bialystok University of Technology and CenStat from Hasselt University, gives us a tremendous opportunity to implement actions which are exceptionally important for European science and higher education. Huge data sets generated in large-scale research projects require expertise in both the field of medical biology and the knowledge of advanced data analysis methods. But why MUB? It is one of the most rapidly developing research centres in the field of medical sciences in Poland. Throughout last 15 years, MUB significantly improved its infrastructure, necessary for the execution of projects in the field of personalized medicine. Increasing the experience and knowledge of students and scientists by using state of the art infrastructure improves the quality of research and enables MUB to join world leaders in the field of -omics research.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз